Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
doi 10.1001/archinternmed.2012.4485
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

Archives of Internal Medicine
2006English

Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Examining Warfarin Underutilization Rates in Patients With Atrial Fibrillation: Detailed Chart Review Essential to Capture Contraindications to Warfarin Therapy

Thrombosis Journal
Hematology
2008English

Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan

Internal Medicine
Internal MedicineMedicine
2004English

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2012English

Anticoagulation in Patients With Atrial Fibrillation. Underuse of Warfarin Is Multifactorial.

BMJ
1993English

Paroxysmal Atrial Fibrillation and Administration of Antiplatelet Therapy Are Still Negative Determinants of Warfarin Use in Non-Valvular Atrial Fibrillation Patients Treated by Japanese Cardiologists

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy